MiCo BioMed Co Ltd
KOSDAQ:214610
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
MiCo BioMed Co Ltd
Net Income (Common)
MiCo BioMed Co Ltd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
MiCo BioMed Co Ltd
KOSDAQ:214610
|
Net Income (Common)
-₩29.9B
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-19%
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Net Income (Common)
-₩5.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Net Income (Common)
₩131.9B
|
CAGR 3-Years
21%
|
CAGR 5-Years
28%
|
CAGR 10-Years
114%
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Net Income (Common)
₩29.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Net Income (Common)
₩32.6B
|
CAGR 3-Years
94%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Net Income (Common)
-₩8.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
MiCo BioMed Co Ltd
Glance View
MiCo BioMed Co. Ltd. engages in the development, manufacture and sale of in vitro diagnosis medical devices and diagnostic reagents. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2015-06-22. The firm operates its business through three segments. The Molecular Diagnosis segment mainly manufactures and sells products such as nucleic acid extraction equipment, gene amplification equipment, reagents, and lab chips. The Biochemical Diagnosis segment mainly manufactures and supplies products such as complex diagnostics, anemia meters, blood glucose meters, medical devices and strips. The Immunodiagnostic Business segment mainly produces and sells immunodiagnostic devices and immunodiagnostic kits.
See Also
What is MiCo BioMed Co Ltd's Net Income (Common)?
Net Income (Common)
-29.9B
KRW
Based on the financial report for Dec 31, 2024, MiCo BioMed Co Ltd's Net Income (Common) amounts to -29.9B KRW.
What is MiCo BioMed Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-19%
Over the last year, the Net Income (Common) growth was -16%. The average annual Net Income (Common) growth rates for MiCo BioMed Co Ltd have been -41% over the past three years , -15% over the past five years , and -19% over the past ten years .
